The efficacy of metformin in pregnant women with polycystic ovary syndrome: A meta-analysis of clinical trials

Journal of Endocrinological Investigation

Volumn 36, Issue 10, 2013, Pages 797-802

  Zheng, J ^a   Shan, P F ^a   Gu, W ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Metformin; Polycystic ovary syndrome; Pregnancy related complications

Indexed keywords

METFORMIN;

ARTICLE; DRUG EFFICACY; EARLY PREGNANCY LOSS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; META ANALYSIS; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY DISORDER; PREGNANT WOMAN; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS;

EID: 84887111250     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8932     Document Type: Article

References (30)

1. Fougner KJ, Vanky E, Carlsen SM. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scand J Clin Lab Invest 2008, 68: 771-6.
2. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980, 50: 113-6.
3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18: 774-800.
4. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005, 83: 1454-60.
5. Bjercke S, Dale PO, Tanbo T, Storeng R, Ertzeid G, Abyholm T. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest 2002, 54: 94-8.
6. Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab 2006, 20: 281-92.
7. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002, 77: 520-5.
8. Diamanti-Kandarakis E, Christakou CD, Kandaraki E, Economou FN. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. Eur J Endocrinol 2010, 162: 193-212.
9. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L,Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertility and Sterility 2001, 75: 46-52.
10. Begum MR, Khanam NN, Quadir E, et al. Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res 2009, 35: 282-6.
11. Khattab S, Mohsen IA, Foutouh IA, Ramadan A, Moaz M, Al-Inany H. Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Gynecol Endocrinol 2006, 22: 680-4.
12. Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM.Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004, 19: 1734-40.
13. Palomba S, Falbo A, Orio F Jr, Zullo F. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2009, 92: 1646-58.
14. Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 2010, 95: E448-55.
15. Khattab S, Mohsen IA, Aboul Foutouh I, et al. Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecol Endocrinol 2011, 27: 789-93.
16. De Leo V, Musacchio MC, Piomboni P, Di Sabatino A, Morgante G. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol 2011, 157: 63-6.
17. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87: 524-9.
18. Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012, 97: 28-38 e25.
19. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 2011, 204: 558 e1-6.
20. Ryan EA. Hormones and insulin resistance during pregnancy. Lancet 2003, 362: 1777-8.
21. Franks S, Gilling-Smith C, Watson H, Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 1999, 28: 361-78.
22. Glueck CJ, Sieve L, Zhu B, Wang P. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome. Metabolism 2006, 55: 345-52.
23. Jakubowicz DJ, Essah PA, Seppala M, et al. Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. J Clin Endocrinol Metab 2004, 89: 833-9.
24. Hu ZY, Liu YX, Liu K, et al. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. J Anat 1999, 194: 183-95.
25. Jensen RB, Chellakooty M, Vielwerth S, Vaag A, Larsen T, Greisen G, et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role? Horm Res 2003, 60 (Suppl 3): 136-48.
26. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005, 365: 785-99.
27. Forsbach-Sanchez G, Tamez-Perez HE, Vazquez-Lara J. Diabetes and pregnancy. Arch Med Res 2005, 36: 291-9.
28. Palomba S, Russo T, Orio F Jr, et al. Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome. Hum Reprod 2006, 21: 457-65.
29. McCarthy EA, Walker SP, McLachlan K, Boyle J, Permezel M. Metformin in obstetric and gynecologic practice: a review. Obstet Gynecol Surv 2004, 59: 118-27.
30. Heard MJ, Pierce A, Carson SA, Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 2002, 77: 669-73.